Prions

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Prions were initially defined as infectious protein agents causing neurodegenerative diseases in mammals.
• The prion concept involves misfolded proteins (PrP) inducing conformational changes in normal proteins via protein-protein interactions.
• The discovery of prions in yeast (Saccharomyces cerevisiae) and fungi (Podospora anserina) expanded their known significance beyond disease.

Purpose of the Study:

• To review the broader significance of prions in both mammals and lower eukaryotes.
• To discuss mechanisms of prion formation, maintenance, and structure.
• To explore prospects for treating prion diseases and identify novel prion-like proteins.

Main Methods:

• Literature review of prion research in mammals and lower eukaryotes.
• Focus on the [PSI+] prion in S. cerevisiae as a model system.
• Analysis of protein-protein interactions and aggregation mechanisms.

Main Results:

• Prions in lower eukaryotes are not pathogenic but mediate heritable phenotypic traits, suggesting adaptive roles.
• The [PSI+] prion in yeast is extensively studied, providing insights into prion propagation.
• Research is ongoing to identify new prion-like proteins and understand their functions.

Conclusions:

• Prions represent a conserved biological phenomenon with diverse roles beyond disease.
• Understanding prion mechanisms in yeast can inform strategies for treating mammalian prion diseases.
• Further research into prion-like proteins may reveal new biological functions and therapeutic targets.